At a glance
- Originator Aventis
- Class
- Mechanism of Action Tumour necrosis factor inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Septic shock
Most Recent Events
- 16 Jan 1996 Discontinued-Preclinical for Septic shock in USA (Parenteral)
- 31 Jul 1995 Preclinical development for Septic shock in USA (Parenteral)